Down-regulation of protein kinase C activity in 1,2-dimethylhydrazine-induced rat colonic tumors

R K Wali1, C L Baum, M J Bolt

  • 1Department of Medicine, University of Chicago Hospitals and Clinics, IL 60637.

Insights

Alterations in protein kinase C activity and distribution are linked to colon cancer development. Increased 1,2-diacylglycerol mass in tumors suggests a role in malignant transformation.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Protein kinase C (PKC) activity alterations are implicated in early colon cancer development.
  • Further investigation is needed to understand PKC's role in multistage carcinogenesis.

Purpose of the Study:

  • To evaluate the role of protein kinase C in the progression of colonic adenocarcinoma.
  • To examine PKC activity and 1,2-diacylglycerol mass in different colonic tissues.

Main Methods:

  • Rats were administered 1,2-dimethylhydrazine (DMH) or a control diluent for 26 weeks.
  • Colonic tissues (tumor, uninvolved mucosa, control) were harvested and fractionated.
  • Protein kinase C activity and 1,2-diacylglycerol mass were measured in cytosolic and membrane fractions.

Main Results:

  • Total protein kinase C activity decreased in DMH-treated rat colonic mucosa and tumors.
  • In uninvolved mucosa, only cytosolic PKC decreased; in tumors, both cytosolic and membrane PKC decreased.
  • 1,2-diacylglycerol mass was significantly elevated in colonic tumors compared to controls.

Conclusions:

  • Altered protein kinase C activity and distribution may contribute to later stages of colon cancer.
  • Increased 1,2-diacylglycerol mass might be a key factor in these PKC alterations.
  • These findings highlight potential therapeutic targets in colon cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...